Latest Risk Management News

AUB Group Limited delivered a robust FY25 performance, with underlying NPAT rising 17.1% to AUD 200.2 million, driven by strategic acquisitions and margin improvements. The company’s aggressive UK retail expansion and diversified portfolio underpin a confident FY26 outlook.

AUB Group Limited has reported a robust FY25 financial performance, highlighted by a 171% increase in underlying net profit after tax and a 15.2% rise in total dividends. Strategic acquisitions and organic growth across divisions underpin the company’s strong momentum.

Symal Group Limited reports a strong first year as an ASX-listed company, exceeding earnings forecasts and advancing its growth through key acquisitions and sustainability initiatives.

Ophir High Conviction Fund reported a robust financial year ending June 2025, with net assets rising nearly 15% and operating profit more than doubling. The Fund’s concentrated portfolio strategy delivered a 24% net return, comfortably outperforming its benchmark.

KKR Credit Income Fund reported a slight dip in net assets for FY2025 but upheld its monthly distributions and reinstated its distribution reinvestment plan, navigating currency headwinds with active hedging.

Ambertech Limited reported a 6% increase in revenue to $101.2 million for FY25, yet net profit after tax fell sharply by 38% to $0.84 million amid inflationary pressures and increased costs. The company declared a fully franked final dividend and remains optimistic about FY26.

360 Capital Group reported a remarkable 1394% increase in statutory profit for FY25, maintaining dividends while advancing its real estate credit platform and announcing a substantial special distribution.

Butn Limited has reported record revenue growth and its first positive operating cash flow for FY25, alongside securing a substantial $100 million funding facility to fuel future expansion.

WAM Microcap Limited reported a robust 27% increase in net profit for FY2025, driven by strong portfolio returns and sustained dividend payments. The company’s investment strategy continues to outperform the market, underpinning an optimistic outlook for micro-cap equities.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Rubicon Water Limited posted its strongest revenue since IPO at $69.1 million in FY25, driven by robust growth in the US and EMEA markets. Despite a $7 million net loss, the company improved cash flow and reduced debt, positioning itself for further global irrigation automation expansion.

EVT Limited reported a solid financial year with normalised revenue rising 1.3% to A$1.237 billion and EBITDA up 6.3%, while net profit after tax surged 593%, driven by operational resilience and strategic growth initiatives including a major hotel management acquisition.